Conservative Treatment for Laryngeal Granuloma with Beclomethasone Inhaler
Author Information
Author(s): MASAHIRO KAWAIDA, HIROYUKI FUKUDA, YOSHIHISA KAWASAKI, AKIHIRO SHIOTANI, NAOYUKI KOHNO
Primary Institution: Tokyo Metropolitan Ohtsuka Hospital
Hypothesis
Can conservative treatment with beclomethasone dipropionate inhalation therapy effectively manage nonspecific granuloma of the larynx?
Conclusion
Beclomethasone dipropionate inhalation therapy showed good results in treating nonspecific granuloma of the larynx, with a 70% efficacy rate.
Supporting Evidence
- Conservative treatment was instituted in 20 cases with good results.
- Therapeutic efficacy was assessed by local findings in the larynx observed with a laryngoendoscope.
- 14 patients had an excellent or good response, for an efficacy rate of 70%.
- All 20 patients used the inhaler on an outpatient basis with no adverse reactions.
Takeaway
Doctors used a special inhaler to help patients with a throat lump feel better, and it worked for most of them.
Methodology
Patients received beclomethasone dipropionate inhalation therapy and were followed up for 6 months to assess therapeutic efficacy.
Limitations
The study lacks long-term follow-up results and a controlled comparison group.
Participant Demographics
The study included 20 patients, with a median age of 49.8 years, consisting of 17 men and 3 women.
Want to read the original?
Access the complete publication on the publisher's website